LAROSA JOSEPH J sold $4.3M of REGN
LAROSA JOSEPH J (EVP General Counsel and Secret) sold 4,466 shares of REGENERON PHARMACEUTICALS, INC. (REGN) at an average of $965.49 ($965.41–$966.11, $4.31M total) across 2 trades on 2026-11-02.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a data point for investors assessing insider sentiment and may influence short‑term price action.
Market read
Regeneron insider sale provides fresh, material information that could affect short‑term trading decisions.
What to watch
No 10b5‑1 plan; sale may be unrelated to company fundamentals.
Background
SEC Form 4 filings disclose insider transactions; they are primary sources of material information.
Ticker impact
EVP General Counsel Larosa Joseph sold 4,466 Regeneron shares for $4.3M on 2026-11-02.
likely pressure as the market prices in the insider sell
A $4.3M sale by a top legal executive is material for a large‑cap biotech and can prompt short‑term downside bias.
Market effects
Minor impact on biotech sector; similar insider sales may be watched.
US market only; no broader regional effect.
Limited to Regeneron investors.
Counterpoint
The sale could be a routine portfolio rebalancing, not a negative signal.
Key entities
- companyRegeneron Pharmaceuticals, Inc.
Biotech firm developing therapeutics.
- personLarosa Joseph J.
EVP General Counsel at Regeneron.



